(RTTNews) - Biohaven Pharmaceuticals (BHVN), on Tuesday announced that the FDA has accepted its New Drug Application for Troriluzole for the treatment of adult patients with spinocerebellar ataxia ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback